La vendita allo scoperto per Research Solutions dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Research Solutions. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Research Solutions (NASDAQ:RSSS) Azioni, Report sulle vendite allo scoperto

Research Solutions

Research Solutions Inc is a holding company. The company provides a cloud-based SaaS research intelligence platform consisting of proprietary software and Internet-based interfaces. Its platform also allows customers to find and download digital versions of STM articles. Platforms and Transactions are packaged as a single solution that enables life science and other research-intensive organizations to speed up research and development activities. The company platform allows customers to initiate orders, manage transactions, automate authentication, obtain reports, and connect seamlessly to corporate intranets.

Research Solutions Inc

WIIM

Bakkt Holdings, Inc. Class A Common Stock

BKKT

Bakkt Holdings shares are trading higher after the company reported a year-over-year increase in Q1 financial results.

Needham analyst Joshua Reilly reiterates Tyler Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TYL#NYSE">TYL</a>) with a Buy and maintains $750 price target.

News

Price Target

Reiteration

Analyst Ratings

Needham Reiterates Buy on Tyler Technologies, Maintains $750 Price Target

RLGT

Radiant Logistics shares are trading higher after the company reported better-than-expected Q3 financial results.

SNGX

Soligenix shares are trading lower after the company reported worse-than-expected Q1 EPS results.

D. Boral Capital analyst Jesse Sobelson maintains US Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USEG#NASDAQ">USEG</a>) with a Buy and maintains $3.5 price target.

USEG

D. Boral Capital Maintains Buy on US Energy, Maintains $3.5 Price Target

CHRS

Coherus BioSciences shares are trading lower. The company reported Q1 financial results.

VTSI

VirTra shares are trading higher after the company reported better-than-expected Q1 financial results.

Landstar also announced today that its Board of Directors declared a quarterly dividend of $0.40 per share payable on June 24, 2025, to stockholders of record as of the close of business on June 5, 2025. This quarterly dividend includes a $0.04 per share increase, or 11% over the amount of the Company's regular quarterly dividend declared following each of the prior three quarters.

Dividends

LSTR

Landstar System Boosts Quarterly Dividend By 11% To $0.40/Share

Nayax (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NYAX#NASDAQ">NYAX</a>) affirms FY2025 sales outlook from $410.00 million-$425.00 million to $410.00 million-$425.00 million vs $410.79 million estimate.

Guidance

NYAX

Nayax Affirms FY2025 Sales Guidance of $410.00M-$425.00M vs $410.79M Est

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>Piper Sandler raised ZoomInfo Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZI#NASDAQ">ZI</a>) price target from $9 to $11. Piper Sandler analyst Brent Bracelin maintained a Neutral rating. ZoomInfo shares closed at $10.31 on Monday. <a href="https://www.benzinga.com/quote/ZI/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Needham cut the price target for Annexon, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANNX#NASDAQ">ANNX</a>) from $16 to $11. Needham analyst Joseph Stringer maintained a Buy rating. Annexon shares closed at $1.77 on Monday. <a href="https://www.benzinga.com/quote/ANNX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Compass Point slashed NexPoint Residential Trust, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NXRT#NYSE">NXRT</a>) price target from $50 to $42.5. Compass Point analyst Merrill Ross downgraded the stock from Buy to Neutral. NexPoint Residential Trust shares closed at $37.53 on Monday. <a href="https://www.benzinga.com/quote/NXRT/analyst-ratings">See how other analysts view this stock.</a></li>
<li>DA Davidson lowered the price target for Rapid7, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPD#NASDAQ">RPD</a>) from $29 to $21. DA Davidson analyst Rudy Kessinger downgraded the stock from Neutral to Underperform. Rapid7 shares closed at $26.74 on Monday. <a href="https://www.benzinga.com/quote/RPD/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Benchmark slashed the price target for indie Semiconductor, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INDI#NASDAQ">INDI</a>) from $8 to $6. Benchmark analyst Cody Acree maintained a Buy rating. indie Semiconductor shares closed at $2.64 on Monday. <a href="https://www.benzinga.com/quote/INDI/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Leerink Partners cut Affimed N.V. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AFMD#NASDAQ">AFMD</a>) price target from $5 to $0.39. Leerink Partners analyst Daina Graybosch downgraded the stock from Outperform to Market Perform. Affimed shares settled at $0.6930 on Monday. <a href="https://www.benzinga.com/quote/AFMD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Barclays increased Stanley Black &amp; Decker, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SWK#NYSE">SWK</a>) price target from $69 to $90. Barclays analyst Julian Mitchell upgraded the stock from Equal-Weight to Overweight. Stanley Black &amp; Decker shares closed at $72.53 on Monday. <a href="https://www.benzinga.com/quote/SWK/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Canaccord Genuity cut BILL Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BILL#NYSE">BILL</a>) price target from $105 to $75. Canaccord Genuity analyst Joseph Vafi maintained a Buy rating. BILL Holdings shares closed at $47.37 on Monday.  <a href="https://www.benzinga.com/quote/BILL/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies increased the price target for Matson, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MATX#NYSE">MATX</a>) from $125 to $135. Jefferies analyst Omar Nokta maintained a Buy rating. Matson shares settled at $113.94 on Monday. <a href="https://www.benzinga.com/quote/MATX/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>HC Wainwright &amp; Co. slashed Neurogene Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NGNE#NASDAQ">NGNE</a>) price target from $50 to $45. HC Wainwright &amp; Co. analyst Mitchell Kapoor maintained a Buy rating. Neurogene shares closed at $17.70 on Monday. <a href="https://www.benzinga.com/quote/NGNE/analyst-ratings">See how other analysts view this stock</a>.</li>
</ul>
Considering buying SWK stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="586" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13075100/image-141-1024x586.png" alt="" class="wp-image-913331" style="width:553px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13075100/image-141-1024x586.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13075100/image-141-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13075100/image-141-768x439.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13075100/image-141.png 1128w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/earnings/25/05/45368490/under-armour-cyberark-software-and-3-stocks-to-watch-heading-into-tuesday">Under Armour, CyberArk Software And 3 Stocks To Watch Heading Into Tuesday</a> </li>
</ul>
Photo via Shutterstock

Pre-Market Outlook

Markets

Trading Ideas

AFMD

ANNX

BILL

INDI

MATX

NGNE

NXRT

Stanley Black & Decker To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday

D. Boral Capital analyst Jesse Sobelson maintains Microvision (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MVIS#NASDAQ">MVIS</a>) with a Buy and lowers the price target from $3 to $2.5.

MVIS

D. Boral Capital Maintains Buy on Microvision, Lowers Price Target to $2.5

ADAP

Adaptimmune Therapeutics shares are trading higher after the company reported better-than-expected Q1 financial results.

Needham analyst Mike Matson reiterates OncoCyte (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OCX#NASDAQ">OCX</a>) with a Buy and maintains $4.25 price target.

Needham Reiterates Buy on OncoCyte, Maintains $4.25 Price Target

Earnings

Earnings Beats

Earnings Misses

Landstar System Q1 EPS $0.85 Misses $0.99 Estimate, Sales $1.15B Beat $1.13B Estimate

SGMO

Sangamo Therapeutics shares are trading lower after the company reported worse-than-expected Q1 financial results.

Bridgemarq Real Estate (TSX:<a class="ticker" href="https://www.benzinga.com/stock/BRE#TSX">BRE</a>) reported quarterly earnings of $0.20 per share. This is a 5.26 percent increase over earnings of $0.19 per share from the same period last year. The company reported $77.97 million in sales this quarter. This is a 562.62 percent increase over sales of $11.77 million the same period last year.

TSX:BRE

Bridgemarq Real Estate Q1 Adj. EPS $0.20 Up From $0.19 YoY, Sales $77.97M Up From $11.77M YoY

ITOS

Trading Halt: Halted at 7:50:00 a.m. ET - Trading Halt: Halt News Pending

Palmer Luckey, the virtual-reality prodigy who sold Oculus to Facebook for $2 billion in 2014, says that payday granted him entry to an ultra-exclusive group chat called the "B Boys Club."
What Happened: The only password to the group chat is a unicorn-level exit: founders must have sold a company for at least $1 billion. "It's all boys who have sold a company for at least $1 billion," Luckey <a href="https://www.youtube.com/watch?v=21I_3VEs0iI">told</a> Peter Diamandis on the "Moonshots" podcast. While he insists women aren't barred, none are in the thread.
That omission is striking given deals like L'Oréal's $1.2 billion purchase of IT Cosmetics from co-founder Jamie Kern Lima in 2016.
By club standards, Instagram's Kevin Systrom and Mike Krieger (<a href="https://www.benzinga.com/news/15/10/5891968/instagrams-fifth-anniversary-how-good-of-a-deal-was-this-for-facebook">sold</a> to Facebook for $1 billion in 2012) would qualify easily. So would WhatsApp's Jan Koum and Brian Acton, who <a href="https://www.benzinga.com/news/14/02/4322191/update-facebook-announces-16b-cash-stock-merger-with-whatsapp">fetched</a> $19 billion two years later. Slack co-founder Stewart Butterfield dwarfs them all, <a href="https://www.benzinga.com/analyst-ratings/analyst-color/20/12/18616683/6-salesforce-analysts-react-to-slack-deal-game-changer-potential">exiting</a> to Salesforce for $27.7 billion in 2021.
See also: <a href="https://www.benzinga.com/25/05/45370909/china-rejects-us-blame-for-fentanyl-crisis-calls-tariff-penalties-unreasonable-amid-easing-trade-tensions">China Rejects US Blame For Fentanyl Crisis, Calls Tariff Penalties Unreasonable Amid Easing Trade Tensions</a>
Some of the planet's richest men, however, are stuck on read. Meta chief Mark Zuckerberg, who&#8217;s worth roughly $226 billion by Bloomberg's latest count, never actually sold Facebook, so he's out, as are Bill Gates, Sam Altman and Warren Buffett.
What To Know: Luckey, now <a href="https://www.forbes.com/profile/palmer-luckey/">valued</a> by Forbes at about $2.5 billion thanks to defense-tech startup Anduril, spends his chat time "shaming" peers into using their fortunes for more than vintage race cars.
"Guys, you have so much money. Why are you not doing what you know is the right thing to do with this capital?" he recalled messaging.
Luckey believes founders should personally build the world they envision instead of outsourcing philanthropy. Some converts are redirecting cash; others, he concedes, still prefer the fast lane. "I'm not saying everyone should become a vigilante crime fighter, but why wouldn't you use your resources to do the thing that you know needs to be done?" Luckey said.
Image via Just dance/Shutterstock
Read next: <a href="https://www.benzinga.com/news/global/25/05/45369837/piers-morgan-tears-into-pakistani-expert-who-says-isi-didnt-know-osama-bin-laden-was-living-near-military-base-all-they-had-to-do-was-get-a-pair-of-binoculars">Piers Morgan Tears Into Pakistani Expert Who Says ISI &#8216;Didn&#8217;t Know&#8217; Osama Bin Laden Was Living Near Military Base: &#8216;All They Had To Do Was Get A Pair Of Binoculars&#8217;</a>

Tech

Oculus Founder Palmer Luckey Reveals He's In An Invite-Only Group Chat With Just One Entry Rule

Kohl's intends to use the net proceeds from the sale of the Notes in a series of transactions resulting in the repayment of borrowings under its revolving credit facility. Kohl's expects to borrow under its revolving credit facility to repay all of its 4.25% notes due 2025 at maturity.

Kohl's Plans $360M Senior Secured Notes Offering Due 2030, Cites Use Of Proceeds For Debt Repayment Strategy

Telsey Advisory Group analyst Dana Telsey maintains FIGS (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIGS#NYSE">FIGS</a>) with a Market Perform and maintains $5 price target.

FIGS

Telsey Advisory Group Maintains Market Perform on FIGS, Maintains $5 Price Target

Press Releases

Research Solutions Reports Fiscal First Quarter 2025 Results

Research Solutions Appoints Sefton Cohen as Chief Revenue Officer

Research Solutions Reports Significant AI Growth & Operational Efficiency Gains

Research Solutions to Announce Second Quarter Fiscal 2025 Results on Thursday, February 13, 2025

Research Solutions Reports Fiscal Second Quarter 2025 Results

Research Solutions Unveils New AI Capabilities to Extract Data from Scientific Literature

Research Solutions Launches Clearinghouse For AI Rights To Scientific Literature

Research Solutions Launches Advanced Reasoning AI Model Optimized For Scientific Research

Small Cap

Research Solutions to Announce Third Quarter Fiscal 2025 Results on Thursday, May 8, 2025

Research Solutions Reports Fiscal Third Quarter 2025 Results

RSSS

Accenture plc Class A Ordinary Shares (Ireland)

Accenture

ASGN

Alpha Technology Group Limited - Class A Ordinary Shares

Alpha Technology Group

BigBear.ai Hldgs

CI&T

Castellum

Cognizant Technology Solutions Corporation - Class A Common Stock

Cognizant Tech Solns

Endava plc American Depositary Shares (each representing one Class A Ordinary Share)

Comments

Research Solutions

Vendite allo scoperto

Research Solutions (NASDAQ:RSSS) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO